Eledon Pharmaceuticals, Inc. (ELDN) vs Pro-Dex, Inc. (PDEX)
A side-by-side comparison of Eledon Pharmaceuticals, Inc. and Pro-Dex, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ELDN
Eledon Pharmaceuticals, Inc.
$2.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PDEX
Pro-Dex, Inc.
$64.92HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ELDN vs PDEX
growth of $100 · dividends reinvested · last 10yELDN -99.0% (-37.2%/yr)PDEX +1400.2% (+31.1%/yr)PDEX compounded faster over this window
Log scale — wide-divergence pair
ELDN PDEX
ELDN vs PDEX: by the numbers
- •PDEX is the larger company ($207M vs $189M market cap).
- •PDEX is profitable (17.62% net margin) while ELDN runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | ELDN | PDEX |
|---|---|---|
| P/E ratio | N/A | 15.76 |
| Forward P/E | N/A | 21.01 |
| PEG ratio | N/A | 0.53 |
| P/S ratio | N/A | 2.67 |
| P/B ratio | 5.73 | 4.35 |
| EV / EBITDA | N/A | 15.10 |
| FCF yield | N/A | 3.33% |
Profitability
| Metric | ELDN | PDEX |
|---|---|---|
| Gross margin | 0.00% | 31.38% |
| Operating margin | 0.00% | 16.75% |
| Net margin | 0.00% | 17.62% |
| ROE | -136.83% | 28.68% |
| ROIC | -74.02% | 14.99% |
Growth (annualized)
| Metric | ELDN | PDEX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 15.32% |
| EPS CAGR (5Y) | N/A | 29.38% |
| Total return CAGR (5Y) | -15.17% | 20.45% |
Frequently asked
- Is ELDN or PDEX more profitable?
- PDEX runs the higher net margin — ELDN at 0.00% versus PDEX at 17.62%.
- How have ELDN and PDEX total returns compared?
- Over the past 10 years, ELDN delivered -37.18% and PDEX delivered 31.26% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Pro-Dex P/E ratioEledon Pharmaceuticals ROEPro-Dex ROEEledon Pharmaceuticals operating marginPro-Dex operating marginEledon Pharmaceuticals revenue growthPro-Dex revenue growthEledon Pharmaceuticals free cash flowPro-Dex free cash flow
Eledon Pharmaceuticals & Pro-Dex appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.